Vestri 6-month safety and benefit study
Project Description:
VESTRI: A 6 month safety and benefit study of inhaled fluticasone propionate/salmeterol combination versus inhaled fluticasone propionate int eh treatment of 6,200 pediatric subjects, 4-11 years olds with persistent asthma.
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
State
COVID-19 Related Data:
N/A